Characteristics of poorly controlled Type 2 diabetes patients in Swiss primary care

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Frei, Anja ^a   Herzog, Stefanie ^a   Woitzek, Katja ^a   Held, Ulrike ^a   Senn, Oliver ^a   Rosemann, Thomas ^a   Chmiel, Corinne ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Determinants of HbA1C; General practitioner; Guideline adherence; Primary care; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

AGED; ARTICLE; BODY MASS; CLINICAL FEATURE; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERIPHERAL VASCULAR DISEASE; PRIMARY MEDICAL CARE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; ATTITUDE TO HEALTH; BLOOD; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEALTH BEHAVIOR; METABOLISM; MIDDLE AGED; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SWITZERLAND; TIME;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GUIDELINE ADHERENCE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862205496     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-70     Document Type: Article

References (35)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87(1):4-14. 10.1016/j.diabres.2009.10.007, 19896746.
2. Kaiser A, Vollenweider P, Waeber G, Marques-Vidal P. Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus study. Diabet Med 2012, 29(2):190-197.
3. Kelly TN, Bazzano LA, Fonseca VA, Thethi TK, Reynolds K, He J. Systematic review: glucose control and cardiovascular disease in type 2 diabetes. Ann Intern Med 2009, 151(6):394-403.
4. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009, 373(9677):1765-1772. 10.1016/S0140-6736(09)60697-8, 19465231.
5. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321(7258):405-412. 10.1136/bmj.321.7258.405, 27454, 10938048.
6. American Diabetes Association: Standards of Medical Care in Diabetes American Diabetes Association Standards of Medical Care in Diabetes. Diabetes care 2010, 33(Supplement 1):S11-S61. 2797382, 20042772, American Diabetes Association: Standards of Medical Care in Diabetes American Diabetes Association.
7. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007, 115(1):114-126.
8. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, et al. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. N Engl J Med 2009, 360(2):129-139. 10.1056/NEJMoa0808431, 19092145.
9. Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358(24):2545-2559.
10. Greenfield S, Billimek J, Pellegrini F, Franciosi M, De Berardis G, Nicolucci A, Kaplan SH. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med 2009, 151(12):854-860.
11. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359(15):1577-1589. 10.1056/NEJMoa0806470, 18784090.
12. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358(24):2560-2572.
13. Frei A, Chmiel C, Schlapfer H, Birnbaum B, Held U, Steurer J, Rosemann T. The Chronic CARe for diAbeTes study (CARAT): a cluster randomized controlled trial. Cardiovasc Diabetol 2010, 9:23. 10.1186/1475-2840-9-23, 2902433, 20550650.
14. Rothenbacher D, Ruter G, Brenner H. Prognostic value of physicians' assessment of compliance regarding all-cause mortality in patients with type 2 diabetes: primary care follow-up study. BMC Fam Pract 2006, 7:42. 10.1186/1471-2296-7-42, 1533834, 16824234.
15. Lowe B, Kroenke K, Herzog W, Grafe K. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord 2004, 81(1):61-66. 10.1016/S0165-0327(03)00198-8, 15183601.
16. Bullinger M, Kirchberger I, Ware J. Der deutsche SF-36 Health Survey Übersetzung und psychometrische Testung eines krankheitsübergreifenden Instruments zur Erfassung der gesundheitsbezogenen Lebensqualität. Zeitschrift für Gesundheitswissenschaften 1995, 3:21-36.
17. Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Med Care 2005, 43(5):436-444. 10.1097/01.mlr.0000160375.47920.8c, 15838407.
18. Rosemann T, Laux G, Droesemeyer S, Gensichen J, Szecsenyi J. Evaluation of a culturally adapted German version of the Patient Assessment of Chronic Illness Care (PACIC 5A) questionnaire in a sample of osteoarthritis patients. J Eval Clin Pract 2007, 13(5):806-813. 10.1111/j.1365-2753.2007.00786.x, 17824876.
19. Gensichen J, Torge M, Peitz M, Wendt-Hermainski H, Beyer M, Rosemann T, Krauth C, Raspe H, Aldenhoff JB, Gerlach FM. Case management for the treatment of patients with major depression in general practices-rationale, design and conduct of a cluster randomized controlled trial-PRoMPT (PRimary care Monitoring for depressive Patient's Trial) [ISRCTN66386086]-study protocol. BMCPublic Health 2005, 5:101.
20. Rosemann T, Joos S, Laux G, Gensichen J, Szecsenyi J. Case management of arthritis patients in primary care: a cluster-randomized controlled trial. Arthritis and rheumatism 2007, 57(8):1390-1397. 10.1002/art.23080, 18050178.
21. van Steenbergen-Weijenburg K, de Vroege L, Ploeger R, Brals J, Vloedbeld M, Veneman T, Hakkaart-van Roijen L, Rutten F, Beekman A, van der Feltz-Cornelis C. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Services Research 2010, 10(1):235. 10.1186/1472-6963-10-235, 2927590, 20704720.
22. Bullinger M, Kirchberger I. SF-36. Fragebogen zum Gesundheitszustand. Handanweisung 1998, Hogrefe, Göttingen.
23. Epping-Jordan JE, Pruitt SD, Bengoa R, Wagner EH. Improving the quality of health care for chronic conditions. Qual Saf Health Care 2004, 13(4):299-305. 10.1136/qshc.2004.010744, 1743863, 15289634.
24. Tsai AC, Morton SC, Mangione CM, Keeler EB. A meta-analysis of interventions to improve care for chronic illnesses. Am J Manag Care 2005, 11(8):478-488. 3244301, 16095434.
25. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness?. Eff Clin Pract 1998, 1(1):2-4.
26. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood) 2001, 20(6):64-78.
27. Mengual L, Roura P, Serra M, Montasell M, Prieto G, Bonet S. Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia. Cardiovasc Diabetol 2010, 9:14. 10.1186/1475-2840-9-14, 2858123, 20350315.
28. Smith SM, Paul G, Kelly A, Whitford DL, O'Shea E, O'Dowd T. Peer support for patients with type 2 diabetes: cluster randomised controlled trial. BMJ 2011, 342:d715. 10.1136/bmj.d715, 3039437, 21324992.
29. Gerber PA, Spirk D, Brandle M, Thoenes M, Lehmann R, Keller U. Regional differences of glycaemic control in patients with type 2 diabetes mellitus in Switzerland: a national cross-sectional survey. Swiss Med Wkly 2011, 141:w13218.
30. Keller R, Radtke T, Krebs H, Hornung R. Der Tabakkonsum der Schweizer Wohnbevölkerung in den Jahren 2001 bis 2010. Tabakmonitoring - Schweizerische Umfrage zum Tabakkonsum 2011, Psychologisches Institut der Universität Zürich, Sozial- und Gesundheitspsychologie, Zürich.
31. Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten GE, Sandbaek A, Sharp SJ, Simmons RK, van den Donk M, Wareham NJ, et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 2011, 378(9786):156-167. 10.1016/S0140-6736(11)60698-3, 3136726, 21705063.
32. Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 2005, 19(2):113-122.
33. Zuberi S, Syed E, Bhatti J. Association of depression with treatment outcomes in Type 2 Diabetes Mellitus: A cross-sectional study from Karachi, Pakistan. BMC Psychiatry 2011, 11(1):27. 10.1186/1471-244X-11-27, 3046918, 21324127.
34. Sequist TD, Fitzmaurice GM, Marshall R, Shaykevich S, Safran DG, Ayanian JZ. Physician performance and racial disparities in diabetes mellitus care. Archives of internal medicine 2008, 168(11):1145-1151. 10.1001/archinte.168.11.1145, 18541821.
35. Kraft E. FMH-Ärztestatistik 2011. 30'849 Ärztinnen und Ärzte für die Schweiz. Schweizerische Ärztezeitung 2012, 93(11):399-403.